Junhua helps the region to leap forward
Changzhou Junhua Medical focuses on the research, development, production and sales of medical polymer materials and implant-grade products such as medical PEEK, PPSU, CF/PEEK thermoplastic composites. As a “high-tech enterprise”, the company adheres to the concept of taking science and technology as the guide and innovation as the driving force, and has established cooperative relations with scientific research institutes, large state-owned enterprises and well-known universities, forming a research and development team with comprehensive knowledge, reasonable structure, complementary advantages, internal and external integration, and strong innovation ability.
The company has established a strict ISO13485 quality management system, and is equipped with medical clean workshops and complete hardware facilities such as processing and testing. At present, Changzhou Junhua Medical has occupied most of the domestic market in the orthopedic medical device industry, with strong downstream application penetration and rich product practical experience.
Settled in Gongyanhui Technology Industrial Park
For many years, Wujin District has focused on local characteristic industries, taking “parks” as the core, accelerating the establishment of industrial circles and strengthening chains, and promoting the leap of regional energy levels. Gongyanhui Science and Technology Industrial Park is a dual-innovation ecological park integrating scientific research, entrepreneurship incubation, achievement transformation, industrial agglomeration, and public services. Gongyanhui Industrial Park will give full play to its carrier advantages, help enterprises with policy applications and investment and financing docking, provide guarantees for enterprise incubation and cluster development, stimulate enterprise innovation vitality, and accelerate the leap of regional energy levels.
By settling in the Gongyanhui Science and Technology Industrial Park, the company not only enjoys policies on taxation, talent introduction and other finance, finance, land, etc., but also brings new opportunities for Junhua Medical’s subsequent sustained and healthy development.
Changzhou Junhua Medical will increase investment in research and development, improve service levels, give full play to the advantages and exemplary role of high-tech enterprises, adhere to the path of technological research and development, high-quality and efficient development, and contribute to the sustained, healthy, rapid and high-quality development of Wujin District’s economy and society.
AKSOPEEK Medical implant grade materials
PEEK material has the characteristics of X-ray transparency, high strength, biocompatibility and an elastic modulus close to that of cortical bone. As a new type of orthopedic medical material, it stands out among many materials and has been widely used in medical fields such as trauma, spine and orthopedic surgery.
The world’s implantable-grade PEEK materials, equipment and manufacturing technologies are monopolized by British companies such as Invibio. The domestic self-sufficiency rate is low, and more than 80% relies on imports. It is under foreign monopoly. Domestic research and development has only begun in recent years. China is facing the dilemma of being “choked”.
In response to the profound challenges faced by my country in the interface structure and biomechanical design, key processing and manufacturing technologies, inspection and testing standards, and clinical application specifications of related implantable devices, five years ago, the company has jointly participated in the research and development of three types of medical implant-grade PEEK materials with scientific research institutes, testing units, medical institutions and other units, mainly to replace similar materials imported from abroad.
In 2021, the company launched the AKSOPEEK series of medical implant-grade materials. The product performance advantages are obvious, filling the domestic gap. The related technology has reached the domestic advanced level. It has become an early and fully qualified domestic supplier of imported medical polymer materials, and has a good market reputation in first-line orthopedic units. This will become a growth point for the company in recent years.
We are very willing to use our experience to assist customers in the entire process from product design, material selection, process, proofing to mass production. We always take it as our responsibility to create value for customers.